Format

Send to

Choose Destination
J Am Pharm Assoc (2003). 2019 Dec 13. pii: S1544-3191(19)30515-1. doi: 10.1016/j.japh.2019.11.009. [Epub ahead of print]

Access to naloxone at community pharmacies under the Massachusetts statewide standing order.

Abstract

OBJECTIVE:

This study aimed to evaluate access to, and barriers to accessing, naloxone at community pharmacies throughout Massachusetts following implementation of new legislation that requires all community pharmacies to maintain a sufficient supply for dispensing under a statewide standing order.

DESIGN:

From September 2018 through January 2019, we conducted a cross-sectional telephone-based survey of Massachusetts pharmacies by having an interviewer pose as a customer seeking naloxone.

SETTING AND PARTICIPANTS:

Community pharmacies were identified from a list of all actively licensed pharmacies provided by the Massachusetts Department of Public Health and one-half were randomly selected for inclusion. Pharmacies that were permanently closed, duplicated on the list, or closed to the general public were excluded from analysis.

OUTCOME MEASURES:

Rates of stocked naloxone, perceived need for identification or prescription, and pricing.

RESULTS:

Of the 524 pharmacies surveyed, 97.7% (n = 512) reported routinely stocking naloxone. Of those, 90.4% (n = 463) had naloxone in stock on the day of contact. Most pharmacies with naloxone in stock did not require a prescription (96.1%; n = 445); at these pharmacies, personal identification was required by 38.9% (n = 180). The average out-of-pocket naloxone nasal spray price was $128.34 ± $40.75.

CONCLUSION:

Nearly all Massachusetts community pharmacies routinely stock naloxone as required by state law; however, barriers remain regarding perceived need for identification and high out-of-pocket costs.

PMID:
31843374
DOI:
10.1016/j.japh.2019.11.009

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center